key: cord-0694779-41bgc0y7
authors: Dell'Antonia, Massimo; Anedda, Speranza; Usai, Federica; Atzori, Laura; Ferreli, Caterina
title: Bullous pemphigoid triggered by COVID‐19 vaccine: Rapid resolution with corticosteroid therapy
date: 2021-11-30
journal: Dermatol Ther
DOI: 10.1111/dth.15208
sha: 292ab6ea5b21e26492595c38906b7de46ada24b7
doc_id: 694779
cord_uid: 41bgc0y7

nan

All authors state that the manuscript is original, it has not been published before and it is not currently being considered for publication elsewhere.

Bullous pemphigoid triggered by rabies vaccine

Case of pemphigoid with immunoglobulin G antibodies to BP180 Cterminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination

Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger

Italian guidelines adapted from the EDF/EADV guidelines

COVID-19 vaccines: the status and perspectives in delivery points of view

Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine

Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis

Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST)

Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination

Reply to "psoriasis exacerbation after COVID-19 vaccination: report of 14 cases from a single Centre

Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination